These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20557473)

  • 1. Influence of plasma glucagon levels on glycemic control in children with type 1 diabetes.
    Urakami T; Nagano N; Suzuki J; Yoshida A; Takahashi S; Mugishima H
    Pediatr Int; 2011 Feb; 53(1):46-9. PubMed ID: 20557473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.
    Fredheim S; Andersen ML; Pörksen S; Nielsen LB; Pipper C; Hansen L; Holst JJ; Thomsen J; Johannesen J; Mortensen HB; Svensson J
    Diabetologia; 2015 Apr; 58(4):828-34. PubMed ID: 25541633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of serum cortisol levels on glycemic control in children with type 1 diabetes.
    Mosbah AA; Abd-Ellatif NA; Sorour EI
    J Egypt Soc Parasitol; 2011 Dec; 41(3):777-84. PubMed ID: 22435169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
    Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2014 Aug; 51(4):567-75. PubMed ID: 24442427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
    Pörksen S; Nielsen LB; Kaas A; Kocova M; Chiarelli F; Orskov C; Holst JJ; Ploug KB; Hougaard P; Hansen L; Mortensen HB;
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2910-6. PubMed ID: 17519307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of variation range in glycated albumin (GA) with increase but not decrease in plasma glucose: implication for the mechanism by which GA reflects glycemic excursion.
    Hashimoto K; Tanikawa K; Nishikawa J; Chen Y; Suzuki T; Koga M
    Clin Biochem; 2015 Apr; 48(6):397-400. PubMed ID: 25562185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.
    Avignon A; Radauceanu A; Monnier L
    Diabetes Care; 1997 Dec; 20(12):1822-6. PubMed ID: 9405900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Setasuban W
    Diabetes Res Clin Pract; 1999 Oct; 46(1):23-7. PubMed ID: 10580612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Ninomiya T; Hata J; Hirakawa Y; Ikeda F; Fukuhara M; Hotta T; Koga M; Nakamura U; Kang D; Kitazono T; Kiyohara Y
    Cardiovasc Diabetol; 2015 Jun; 14():84. PubMed ID: 26099223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sodium glucose cotransporter-2 affects HbA1c levels in people with insulin-dependent diabetes mellitus and differing levels of glucagon.
    Okada J; Yamada E; Okada S; Yamada M
    Prim Care Diabetes; 2020 Oct; 14(5):570-571. PubMed ID: 31917118
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study.
    Gomez-Sanchez L; Garcia-Ortiz L; Patino-Alonso MC; Recio-Rodriguez JI; Feuerbach N; Marti R; Agudo-Conde C; Rodriguez-Sanchez E; Maderuelo-Fernandez JA; Ramos R; Gomez-Marcos MA;
    PLoS One; 2017; 12(4):e0175982. PubMed ID: 28414819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP-4 inhibitor treatment: β-cell response but not HbA
    Kozlovski P; Bhosekar V; Foley JE
    Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon responses to hypoglycemia in children and adolescents with IDDM.
    Singer-Granick C; Hoffman RP; Kerensky K; Drash AL; Becker DJ
    Diabetes Care; 1988 Sep; 11(8):643-9. PubMed ID: 3065002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
    Koga M; Murai J; Morita S; Saito H; Kasayama S
    J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
    Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
    Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.